Episode #28: November 2020 – Compounding, Controlled Substances, and Legislative Agenda

What, Why & How
18/11/2020 18 min Episodio 28
Episode #28: November 2020 – Compounding, Controlled Substances, and Legislative Agenda

Listen "Episode #28: November 2020 – Compounding, Controlled Substances, and Legislative Agenda"

Descargar episodio Ver en sitio original

Episode Synopsis

Following the November 17 Board of Pharmacy meeting, IPA's Director of Public Affairs, Casey Ficek, and Sue Mears from the Board of Pharmacy discuss board action on the FDA’s memorandum of understanding regarding compounding, proposed rules impacting controlled substances and the PMP, and the Board’s legislative agenda.

More episodes of the podcast What, Why & How

Episode #59: September 2025 – Standard of Care, Immunizations & Updates from the Board 25/09/2025
Episode #58: July 2025 – Legislative Session Recap: The Road to PBM Reform 14/08/2025
Episode #57: April 2025 – NABP: The UPJE and Future of License Portability 21/04/2025
Episode #56: March 2025 – PBM Whack-A-Mole 07/04/2025
Episode #55: February 2025 – Pharmacists in Elected Office 14/02/2025
Episode #54: January 2025 – IPA Legislative Briefing 27/01/2025
Episode #53: December 2024 – Federal Advocacy: 2024 Recap 27/12/2024
Episode #52: November 2024 – Standard of Care in Pharmacy Practice: Idaho + Alaska 27/11/2024
Episode #51: October 2024 – Provider Status: Iowa Medicaid 24/10/2024
Episode #50: August 2024 – Iowa Board of Pharmacy: New Executive Director & New Rules 05/09/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA